Baillie Gifford - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 86 filers reported holding CUREVAC N V in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of CUREVAC N V
ValueSharesWeighting
Q2 2022$3,909,000
-94.9%
287,249
-92.7%
0.00%
-92.6%
Q1 2022$76,702,000
-43.0%
3,911,347
-0.3%
0.05%
-27.0%
Q4 2021$134,610,000
-37.5%
3,923,340
-0.4%
0.07%
-34.5%
Q3 2021$215,243,000
-46.9%
3,940,731
-28.5%
0.11%
-42.6%
Q2 2021$405,261,000
-24.0%
5,515,262
-5.4%
0.20%
-33.9%
Q1 2021$533,221,000
+37.0%
5,830,101
+21.4%
0.30%
+37.3%
Q4 2020$389,271,000
+114.6%
4,801,656
+23.2%
0.22%
+73.6%
Q3 2020$181,381,0003,896,4750.12%
Other shareholders
CUREVAC N V shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 1,709,781$23,300,00017.91%
Pinz Capital Management, LP 40,200$547,0000.38%
Parametrica Management Ltd 13,513$184,0000.20%
MQS Management LLC 16,176$220,0000.15%
Quantamental Technologies LLC 11,552$157,0000.07%
Ergoteles LLC 98,100$1,335,0000.04%
Virtus ETF Advisers LLC 7,676$104,0000.04%
Green Alpha Advisors, LLC 12,247$167,0000.04%
ETF MANAGERS GROUP, LLC 53,789$746,0000.02%
Quantbot Technologies LP 14,800$201,0000.02%
View complete list of CUREVAC N V shareholders